Stamford, CT -- (SBWIRE) -- 01/23/2014 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Antares Pharma Inc (NASDAQ:ATRS), First Majestic Silver Corp (NYSE:AG), Chelsea Therapeutics International Ltd. (NASDAQ:CHTP), Nektar Therapeutics (NASDAQ:NKTR)
Antares Pharma Inc (NASDAQ:ATRS) opened the session at $4.96, trading in a range of $4.78 - $4.97. The stock showed a negative performance of -3.23% in the last trading session from its previous close of $4.95 and closed at $4.79. The stock traded on a volume of 1.38 million shares and the average volume of the stock remained 1.51 million shares. Antares Pharma, Inc. (Antares) is a pharma company that focuses on self-injection pharmaceutical products and technologies and topical gel-based products. The Company’s subcutaneous and intramuscular injection technology platforms include Vibex disposable pressure-assisted auto injectors, Vision reusable needle-free injectors, and disposable multi-use pen injectors. In the injector area, it has licensed its reusable needle-free injection device for use with human growth hormone (hGH) to Teva, Ferring Pharmaceuticals BV (Ferring) and JCR Pharmaceuticals Co., Ltd. (JCR), with Teva and Ferring being its two primary customers.
Has ATRS Found The Bottom and Ready To Move Up? Find Out Here
First Majestic Silver Corp (NYSE:AG) traded 1.15 million shares in the last business day while the average volume of the stock remained 1.22 million shares. The stock showed a negative movement of -3.23% to end at $10.80. The 52 week range of the stock remained $8.81 - $19.41. First Majestic Silver Corp. (First Majestic) is engaged in acquiring, exploring and developing silver properties and producing silver in Mexico. The Company has five operating mines located in Mexico, two development projects in Mexico, one retail market segment in Canada and one silver trading segment in Europe. Its five producing mines in Mexico include the La Encantada Silver Mine in Coahuila State, the La Parrilla Silver Mine in Durango State, the San Martin Silver Mine in Jalisco State, the La Guitarra Silver Mine in Mexico State and the Del Toro Silver Mine in Zacatecas State. Its two advanced-stage development silver projects include the La Luz Silver Project in San Luis Potosi State, and the Plomosas Silver Project in Sinaloa State.
Has AG Found The Bottom And Ready To Gain Momentum? Find Out Here
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) reported 3.93 million shares were exchanged during the last trade, while the average volume is about 5.51 million shares. The stock dropped -3.03% and finished the day at $4.64. The beta of the stock is recorded at 1.36. Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), associated with primary autonomic failure and falls related to NOH in Parkinson’s Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension (IDH), fibromyalgia, adult attention deficit hyperactivity disorder (ADHD), chronic fatigue syndrome (CFS), freezing of gait in PD and Down syndrome.
Why Should Investors Buy CHTP After the Recent Fall? Just Go Here and Find Out
Nektar Therapeutics (NASDAQ:NKTR) shares dropped -3.03 percent from its previous close of $13.51 to close at $13.10. Traded with volume of 1.31 million shares in the prior session and the average volume of the stock remained 692,221 shares. Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company's product pipeline is consisted of early to late stage drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. Its research and development activities involve both small molecule and biologic drug candidates.
Will NKTR Get Buyers Even After The Recent Rally? Find Out Here
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Our Penny Stock Newsletter also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Read full disclaimer at: http://www.jetlifepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)